Certest will showcase its solutions in diagnostics and raw materials at AACC 2023
Exhibit to include rapid tests, RT-PCR tests (based on molecular biology), chemiluminescence (CLIA), and turbidimetry, in addition to raw materials for diagnostic product manufacturers
8 Jun 2023
CerTest Biotec, a company specialized in the development, manufacturing, and commercialization of solutions for the diagnosis of infectious diseases, is preparing to participate in the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo. This year, the event will take place in Anaheim, California, on July 25 - 27.
CerTest will present its latest innovations in the diagnosis of infectious diseases, with a clear focus on the flexibility of its products and processes, as well as the speed and accuracy of results. It will showcase a wide range of solutions, including rapid tests, RT-PCR tests (based on molecular biology), chemiluminescence (CLIA), and turbidimetry, in addition to raw materials for diagnostic product manufacturers.
One of the highlights of CerTest's participation at AACC 2023, will be the demonstration of its VIASURE Complete System. This integrated system offers a comprehensive solution for the diagnosis of infectious diseases, providing fast and reliable results that improve workflow in the diagnostic laboratory. Thanks to its advanced technology, VIASURE solutions deliver exceptional performance and increased efficiency in diagnostic laboratories.
In addition to product and solution showcases, CerTest is also involved in research and will present up to 14 publications in the form of posters at AACC, reflecting the latest studies conducted by the company, mainly in the field of molecular biology.
